NO165177C - Fremgangsmaate for fremstilling av et basesalt av piroxicam - Google Patents

Fremgangsmaate for fremstilling av et basesalt av piroxicam

Info

Publication number
NO165177C
NO165177C NO841611A NO841611A NO165177C NO 165177 C NO165177 C NO 165177C NO 841611 A NO841611 A NO 841611A NO 841611 A NO841611 A NO 841611A NO 165177 C NO165177 C NO 165177C
Authority
NO
Norway
Prior art keywords
piroxicam
preparing
procedure
basic salt
dosage forms
Prior art date
Application number
NO841611A
Other languages
English (en)
Other versions
NO165177B (no
NO841611L (no
Inventor
Melvin Mackenzie Noseworthy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO841611L publication Critical patent/NO841611L/no
Publication of NO165177B publication Critical patent/NO165177B/no
Publication of NO165177C publication Critical patent/NO165177C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO841611A 1983-04-25 1984-04-24 Fremgangsmaate for fremstilling av et basesalt av piroxicam NO165177C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48830383A 1983-04-25 1983-04-25

Publications (3)

Publication Number Publication Date
NO841611L NO841611L (no) 1984-10-26
NO165177B NO165177B (no) 1990-10-01
NO165177C true NO165177C (no) 1991-01-09

Family

ID=23939186

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841611A NO165177C (no) 1983-04-25 1984-04-24 Fremgangsmaate for fremstilling av et basesalt av piroxicam

Country Status (28)

Country Link
EP (1) EP0123520B1 (no)
JP (1) JPS59205375A (no)
KR (1) KR840008345A (no)
AT (1) ATE36531T1 (no)
AU (1) AU548451B2 (no)
BG (1) BG40810A3 (no)
CA (1) CA1213220A (no)
CS (1) CS246078B2 (no)
DD (1) DD219672A5 (no)
DE (1) DE3473454D1 (no)
DK (1) DK165168C (no)
EG (1) EG17887A (no)
ES (1) ES531866A0 (no)
FI (1) FI82377C (no)
GR (1) GR81938B (no)
GT (1) GT198404085A (no)
HU (1) HU194217B (no)
IE (1) IE57327B1 (no)
IL (1) IL71598A (no)
MX (1) MX159889A (no)
NO (1) NO165177C (no)
NZ (1) NZ207930A (no)
PH (1) PH18864A (no)
PL (1) PL144064B1 (no)
PT (1) PT78473B (no)
RO (1) RO88420A (no)
YU (1) YU44232B (no)
ZA (1) ZA843013B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
IN160683B (no) * 1981-06-01 1987-07-25 Pfizer

Also Published As

Publication number Publication date
DK204484D0 (da) 1984-04-24
JPH0251527B2 (no) 1990-11-07
PT78473B (en) 1986-08-28
FI82377C (fi) 1991-03-11
IE57327B1 (en) 1992-07-29
HU194217B (en) 1988-01-28
AU2716084A (en) 1984-11-01
EG17887A (en) 1991-03-30
JPS59205375A (ja) 1984-11-20
IL71598A0 (en) 1984-07-31
MX159889A (es) 1989-09-27
IL71598A (en) 1987-01-30
KR840008345A (ko) 1984-12-14
FI841604A (fi) 1984-10-26
ES8505365A1 (es) 1985-05-16
IE840982L (en) 1984-10-25
NO165177B (no) 1990-10-01
DK165168C (da) 1993-03-08
EP0123520A1 (en) 1984-10-31
BG40810A3 (en) 1987-02-16
DD219672A5 (de) 1985-03-13
PH18864A (en) 1985-10-21
CA1213220A (en) 1986-10-28
DK204484A (da) 1984-10-26
ATE36531T1 (de) 1988-09-15
ES531866A0 (es) 1985-05-16
EP0123520B1 (en) 1988-08-17
RO88420A (ro) 1986-01-30
FI82377B (fi) 1990-11-30
YU72484A (en) 1988-04-30
GT198404085A (es) 1985-10-16
DK165168B (da) 1992-10-19
PL144064B1 (en) 1988-04-30
NZ207930A (en) 1986-09-10
AU548451B2 (en) 1985-12-12
PT78473A (en) 1984-05-01
FI841604A0 (fi) 1984-04-24
ZA843013B (en) 1985-12-24
CS246078B2 (en) 1986-10-16
HUT34023A (en) 1985-01-28
GR81938B (no) 1984-12-12
YU44232B (en) 1990-04-30
DE3473454D1 (en) 1988-09-22
NO841611L (no) 1984-10-26
PL247378A1 (en) 1985-03-26

Similar Documents

Publication Publication Date Title
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
BG51042A3 (en) Process for the preparation of anhydrous, crystalline sodium salt of 5- chloro- 3(2- thenoyl)- 2- axindole- 1- carboxamyde
NO165177C (no) Fremgangsmaate for fremstilling av et basesalt av piroxicam
KR880005927A (ko) 카복실산 아미드의 용도
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
ES8304977A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
PT74744B (fr) Procede de preparation de derives de phenethanolamine et de compositions pharmaceutiques les contenant
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
SE7704480L (sv) Aminoalkoholer
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
HUT35519A (en) Process for producing of anelgetic medical preparatives
JPS525755A (en) Process for preparation of 3-amino-4-homotwistane and its acid salts